Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $98.4550 (-4.44%) ($98.2550 - $98.4550) on Tue. Feb. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 26 | Latest Price | $98.4550(-4.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -3.7% a day on average for past five trading days. | Weekly Trend | LGND declines -4.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWO(62%) IBB(61%) IWM(61%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.73% in a week (0% probabilities). VIXM(-28%) UUP(-20%) VXX(-17%) EDOC(-7%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $117.87 | 5 Day Moving Average | $111.99(-12.09%) | 10 Day Moving Average | $116.5(-15.49%) | 20 Day Moving Average | $117.87(-16.47%) | To recent high | -40.6% | To recent low | 0% | Market Cap | $1.582b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |